Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Helmholtz
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage company founded as a spin-off from the Max Delbrück Center in Berlin and pioneers next-generation CAR T-cell therapies for treating a broad range of hematologic malignancies and autoimmune diseases.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berlin Germany
HQ
company site